


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:21Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405044" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405044</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Res</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Res</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Pharmaceutical Research</journal-title></journal-title-group><issn pub-type="ppub">0724-8741</issn><issn pub-type="epub">1573-904X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405044</article-id><article-id pub-id-type="pmcid-ver">PMC12405044.1</article-id><article-id pub-id-type="pmcaid">12405044</article-id><article-id pub-id-type="pmcaiid">12405044</article-id><article-id pub-id-type="pmid">40790392</article-id><article-id pub-id-type="doi">10.1007/s11095-025-03905-4</article-id><article-id pub-id-type="publisher-id">3905</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Dissolution Profile of Tosufloxacin Tosylate in Biorelevant Bicarbonate Buffer Containing Sodium Chloride: Precipitation of Hemi-hydrochloride Salt at the Particle Surface</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Okamoto</surname><given-names initials="N">Nanami</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names initials="H">Hibiki</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5652-1786</contrib-id><name name-style="western"><surname>Sugano</surname><given-names initials="K">Kiyohiko</given-names></name><address><email>suganok@fc.ritsumei.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0197nmd03</institution-id><institution-id institution-id-type="GRID">grid.262576.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 8863 9909</institution-id><institution>Molecular Pharmaceutics Lab, College of Pharmaceutical Sciences, </institution><institution>Ritsumeikan University, </institution></institution-wrap>1-1-1, Noji-Higashi, Kusatsu, Shiga 525-8577 Japan </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>42</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><fpage>1363</fpage><lpage>1372</lpage><history><date date-type="received"><day>19</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="11095_2025_Article_3905.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">The purpose of the present study was to investigate the dissolution profile of tosufloxacin tosylate monohydrate (TFLX TS) in biorelevant bicarbonate buffer (BCB). TFLX is a zwitterionic drug (p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic></sub>: 5.8 and 8.7), formulated as tosylate salt to enhance its dissolution.</p></sec><sec><title>Methods</title><p id="Par2">The dissolution profiles were measured in BCB or phosphate buffer (PPB) at pH 6.5 with buffer capacity (&#946;)&#8201;=&#8201;0.88 or 4.4&#160;mM/pH, containing NaCl or Na<sub>2</sub>SO<sub>4</sub> (<italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M). The residual particles were analyzed by powder X-ray diffraction. In a separate study, the particle surface of TFLX TS after contact with BCB was observed by scanning electron microscopy and real-time polarized light microscopy. The pH solubility profile of TFLX was measured using HCl and TS solutions.</p></sec><sec><title>Results</title><p id="Par3">TFLX TS dissolved less in the NaCl media than in the Na<sub>2</sub>SO<sub>4</sub> media. It also dissolved less in PPB than in BCB (at &#946;&#8201;=&#8201;4.4&#160;mM/pH), and less at &#946;&#8201;=&#8201;4.4&#160;mM/pH than at 0.88&#160;mM/pH. The analysis of residual particles indicated that the hemi-hydrochloride salt (TFLX 1/2HCl) precipitated on the particle surface of TFLX TS in the NaCl media. In contrast, the free form of TFLX precipitated in the Na<sub>2</sub>SO<sub>4</sub> media. The pH solubility profile matched the hemi-hydrochloride stoichiometry (<italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub>&#8201;=&#8201;[TFLX&#8729;H<sup>+</sup>][TFLX][Cl<sup>&#8722;</sup>]).</p></sec><sec><title>Conclusion</title><p id="Par4">The dissolution of TFLX TS in the NaCl media was suppressed by the precipitation of TFLX 1/2HCl on the particle surface. This is an important case showing that NaCl can suppress the dissolution profile of a non-HCl drug salt at a neutral pH.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s11095-025-03905-4.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Biorelevant</kwd><kwd>Chloride ion</kwd><kwd>Dissolution</kwd><kwd>Particle surface</kwd><kwd>Salt</kwd></kwd-group><funding-group><award-group><funding-source><institution>Ritsumeikan University</institution></funding-source></award-group><open-access><p>Open Access funding provided by Ritsumeikan University.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Dissolution tests have been widely used to assess the oral absorption of a drug. Biorelevant dissolution test media have been used to evaluate the dissolution, supersaturation, and precipitation profiles of a drug (hereinafter referred to as the dissolution profile) in the gastrointestinal tract [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In the small intestine, the pH value is maintained by bicarbonate buffer (BCB) [<xref ref-type="bibr" rid="CR3">3</xref>]. BCB undergoes the chemical equilibrium of HCO<sub>3</sub><sup>&#8722;</sup>&#8201;+&#8201;H<sup>+</sup> &#8201;&#8652;&#8201;H<sub>2</sub>CO<sub>3</sub>&#8201;&#8652;&#8201;H<sub>2</sub>O&#8201;+&#8201;CO<sub>2</sub> [<xref ref-type="bibr" rid="CR4">4</xref>]. The reaction rate of CO<sub>2</sub> hydration is significantly slower than that of H<sub>2</sub>CO<sub>3</sub> dehydration. This unique property of BCB affects the dissolution profile of ionizable drugs and excipients [<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. However, BCB has not been widely used because of practical difficulties [<xref ref-type="bibr" rid="CR12">12</xref>]. Instead, phosphate buffer solutions (PPB) have been widely used as dissolution media. Recently, the floating lid method was developed as a simple and versatile method to use BCB [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>]. This method does not require CO<sub>2</sub> bubbling, thus avoiding the formation of surfactant foam and the artifact stimulation of crystal precipitation [<xref ref-type="bibr" rid="CR19">19</xref>]. In addition, sodium chloride (NaCl) is typically used to adjust the osmolarity and ionic strength (<italic toggle="yes">I</italic>) of biorelevant media [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The osmolarity and <italic toggle="yes">I</italic> of a fluid would be important for the assessment of controlled-release formulations [<xref ref-type="bibr" rid="CR20">20</xref>]. However, the impact of NaCl on the dissolution profile of drug substances has been little investigated.</p><p id="Par6">Tosufloxacin tosylate monohydrate (TFLX TS) shows incomplete bioavailability in humans [<xref ref-type="bibr" rid="CR21">21</xref>]. TFLX is a zwitterionic drug with p<italic toggle="yes">K</italic><sub><italic toggle="yes">a1</italic></sub>&#8201;=&#8201;5.8 and p<italic toggle="yes">K</italic><sub><italic toggle="yes">a2</italic></sub>&#8201;=&#8201;8.7 (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR21">21</xref>]. TFLX shows poor equilibrium solubility (<italic toggle="yes">S</italic><sub><italic toggle="yes">eq</italic></sub>) at pH 6.5 (<italic toggle="yes">S</italic><sub><italic toggle="yes">eq</italic></sub>&#8201;=&#8201;2.1&#160;&#956;g/mL at 37&#176;C) [<xref ref-type="bibr" rid="CR22">22</xref>]. Therefore, TFLX is formulated as a salt with a strong acid (p-toluenesulfonic acid), and L-aspartic acid was added as an acidifying excipient in the commercial tablet. However, in our previous study, the TFLX TS tablet still showed poor dissolution profiles in the BCB-based fasted state simulated intestinal fluid (BCB-FaSSIF) at pH 6.5 [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In those studies, the dissolution profiles of the TFLX TS tablet in BCB differed from those in PPB. Because the equilibrium solubility of TFLX was increased by bile micelles in FaSSIF [<xref ref-type="bibr" rid="CR24">24</xref>], the other component of biorelevant media would have suppressed the dissolution process of TFLX TS.
</p><p id="Par7">The purpose of this study was to investigate the dissolution profile of TFLX TS drug substance in biorelevant BCB in detail. This study used BCB that reflects the intestinal environment for dissolution tests (pH 6.5, 10&#160;mM (buffer capacity (&#946;)&#8201;=&#8201;4.4&#160;mM/pH), containing NaCl (<italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M)). For comparison, PPBs with the same &#946; and <italic toggle="yes">I</italic> were used. To examine the effect of NaCl while maintaining <italic toggle="yes">I</italic>, Na<sub>2</sub>SO<sub>4</sub> was used to adjust <italic toggle="yes">I</italic> instead of NaCl. Na<sub>2</sub>SO<sub>4</sub> was selected because it is composed of a non-halogen divalent anion (SO<sub>4</sub><sup>2&#8722;</sup>) that is considered to behave differently from Cl<sup>&#8722;</sup>. In addition, since a decrease in &#946; has been shown to increase the dissolution of a salt-form drug [<xref ref-type="bibr" rid="CR25">25</xref>], the dissolution profiles at a lower &#946; value were also investigated (&#946;&#8201;=&#8201;0.88&#160;mM/pH).
<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Chemical structure of tosufloxacin tosylate monohydrate (TFLX TS) (<bold>A</bold>), the scanning electron microscope image (SEM) (<bold>B</bold>), and the polarized light microscope (PLM) image (<bold>C</bold>) of initial TFLX TS particles. Fine and coarse particles were prepared by recrystallization from an ethanol&#8211;water mixture (see text). The samples for PLM were dispersed in silicone oil.</p></caption><graphic id="MO1" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec2"><title>Materials and Methods</title><sec id="Sec3"><title>Materials</title><p id="Par8">Tosufloxacin tosylate monohydrate (TFLX TS), p-toluenesulfonic acid monohydrate, NaH<sub>2</sub>PO<sub>4</sub>&#8729;2H<sub>2</sub>O, NaHCO<sub>3</sub>, NaCl, Na<sub>2</sub>SO<sub>4</sub>, 8&#160;mol/L NaOH, and 6&#160;mol/L HCl were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). Ethanol was purchased from Maruishi Pharmaceutical Co., Ltd. (Osaka, Japan).</p></sec><sec id="Sec4"><title>Methods</title><sec id="Sec5"><title>Preparation of Sample and Reference Materials</title><p id="Par9">Tosufloxacin tosylate monohydrate (TFLX TS) was recrystallized before use for dissolution tests. TFLX TS obtained from the supplier (3.41&#160;mmol) was added to an ethanol&#8211;water mixture (1:1 (v:v), 40&#160;mL) in a conical beaker. A small excess amount of p-toluenesulfonic acid (0.341&#160;mmol) was added to shift the equilibrium to the salt form. TFLX TS was completely dissolved by heating to 70&#176;C. The solution was stirred using a magnetic stirrer for 6&#160;h at room temperature (25&#8201;&#177;&#8201;2&#176;C) to obtain fine particles. Coarse particles were obtained by slowly cooling the solution to room temperature in a styrofoam container for 12&#160;h without stirring. The precipitated crystals were harvested by vacuum filtration and analyzed by powder X-ray diffraction (PXRD) (Supplementary Material Figure <xref rid="MOESM1" ref-type="media">S1</xref>). The polarized light microscope image analysis indicated that the average sizes of fine and coarse particles were about 11 and 217&#160;&#956;m, respectively (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C) [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par10">The free form of TFLX (TFLX FF) was prepared as follows. TFLX TS (9.82&#160;mmol) was completely dissolved in an ethanol&#8211;water mixture (1:1 (v/v), 400&#160;mL) at 70&#176;C. An equimolar amount of NaOH (1&#160;M NaOH, 9.82&#160;mL) was added to induce the precipitation of TFLX FF. The suspension was left to stand for 12&#160;h at room temperature without stirring. The precipitated crystals were collected by vacuum filtration and analyzed by PXRD and thermogravimetry/differential thermal analysis (TG/DTA). No PXRD peak of TFLX TS was observed (Supplementary Material Figure <xref rid="MOESM1" ref-type="media">S1</xref>). The TG/DTA data suggested that it includes about 2 H<sub>2</sub>O per TFLX after vacuum filtration (Supplementary Material Figure S2). After storing under 75% relative humidity (RH) for 3&#160;months at room temperature, the sample contained about 2.2 H<sub>2</sub>O. After storing under 100% RH for 3&#160;months, the sample contained about 3.7 H<sub>2</sub>O (measured immediately after removal from the chamber), suggesting that it can form a higher number of hydrates in aqueous media. However, it rapidly returned to about 2H<sub>2</sub>O during handling at ambient humidity. Therefore, this material was referred to as TFLX FF in this report.</p><p id="Par11">The hydrochloride salt of TFLX was prepared as follows. TFLX FF (0.21&#160;mmol) was added to distilled water (500&#160;mL) and completely dissolved by the addition of NaOH (1.0&#160;M, 0.42&#160;mL) at 70&#176;C. HCl (1.0&#160;M, 0.63&#160;mL) was added to induce the precipitation of an HCl salt. The suspension was left to stand for 12&#160;h at room temperature without stirring. The precipitated crystals were analyzed by PXRD and TG/DTA. No PXRD peak of TFLX FF was observed (Supplementary Material Figure <xref rid="MOESM1" ref-type="media">S1</xref>). The pH titration measurement suggested the formation of a hemi-hydrochloride (TFLX 1/2HCl) composed of one protonated TFLX (TFLXH<sup>+</sup>), one free-form TFLX, and one chloride ion (Cl<sup>&#8722;</sup>) (Supplementary Material Figure S3). The solubility product (<italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub>) is defined as <italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub>&#8201;=&#8201;[TFLXH<sup>+</sup>][TFLX][Cl<sup>&#8722;</sup>]. The pH solubility profile measured by adjusting the pH using HCl also supported this stoichiometry (discussed later). The TG/DTA data indicated that it includes 0.54 H<sub>2</sub>O per TFLX (Supplementary Material Figure S4). After storing under 75% RH for 2&#160;months at room temperature, the sample contained about 0.74 H<sub>2</sub>O. After storing under 100% RH for 3&#160;months, the sample contained about 10.0 H<sub>2</sub>O (measured immediately after removal from the chamber), suggesting it can form a higher number of hydrates in aqueous media. Similar to the case of TFLX FF, it rapidly returned to about 0.5 H<sub>2</sub>O during handling at ambient humidity. Therefore, this material was referred to as TFLX 1/2HCl in this report.</p><p id="Par12">Single-crystal X-ray structure analysis is ideal for confirming the crystal form and stoichiometry. However, no suitable crystals were available for either TFLX FF or TFLX 1/2HCl.</p></sec><sec id="Sec6"><title>Dissolution Test</title><p id="Par13">A mini-paddle dissolution apparatus (NTR-6200A; Toyama Sangyo Co., Ltd., Osaka, Japan) was used for the dissolution test. A NaHCO<sub>3</sub> solution (98&#160;mL, 2.04&#160;mM or 10.2&#160;mM), prewarmed at 37&#176;C in a container for at least 30&#160;min, was added to each vessel. The temperature was maintained at 37&#176;C. The paddle rotation speed was set to 100&#160;rpm. An HCl solution (2.0&#160;mL) (0.033, or 0.165&#160;M) was added to adjust the pH value to pH 6.5 (the total volume was 100&#160;mL). These HCl concentrations were experimentally pre-determined to give pH 6.5 after adding to the NaHCO<sub>3</sub> solutions (BCB 2.0 or 10&#160;mM (&#946;&#8201;=&#8201;0.88 or 4.4&#160;mM/pH), <italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M adjusted by NaCl or Na<sub>2</sub>SO<sub>4</sub>) (Table<xref rid="Tab1" ref-type="table">&#160;I</xref>). The solution surface was covered with a floating lid for a mini-vessel [<xref ref-type="bibr" rid="CR27">27</xref>]. The conditions of PPB were the same as BCB buffer, including the use of the floating lid (pH 6.5, 1.6 or 8.0&#160;mM (&#946;&#8201;=&#8201;0.88 or 4.4&#160;mM/pH), <italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M adjusted by NaCl or Na<sub>2</sub>SO<sub>4</sub>) (Table<xref rid="Tab1" ref-type="table">&#160;I</xref>). TFLX TS (30&#160;mg, fine particles) was added to each vessel. At specified time intervals, a small volume of samples (0.5&#160;ml) was withdrawn and immediately filtered (hydrophilic PVDF, &#966;&#8201;=&#8201;4.0&#160;mm, pore size: 0.22&#160;&#181;m, Merck). The first few droplets were discarded to avoid filter adsorption. The filtrate was diluted with an appropriate medium, and the concentration of TFLX was measured by UV absorbance at 365&#160;nm (SH-9500lab, CORONA ELECTRIC, Ibaraki, Japan). The final pH value was measured using a pH meter (300-P&#8211;C, HORIBA Advanced Techno, Co., Ltd., Kyoto, Japan). The residual particles were collected by vacuum filtration and analyzed by PXRD.
</p><p id="Par14">The &#946; values were calculated by the Van Slyke equation [<xref ref-type="bibr" rid="CR28">28</xref>] using the p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic></sub> values close to pH 6.5 (BCB: p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic></sub>&#8201;=&#8201;6.05 (for <italic toggle="yes">I</italic>&#8201;=&#8201;0.15&#160;M, at 37&#176;C), PPB: p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic></sub>&#8201;=&#8201;6.69 (for <italic toggle="yes">I</italic>&#8201;=&#8201;0.15&#160;M, at 37&#176;C)), assuming the activity coefficient of H<sup>+</sup> is 1 [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec7"><title>Scanning Electron Microscopy of TFLX TS Particles Suspended in Bicarbonate Buffer</title><p id="Par15">The coarse crystalline particles of TFLX TS were used for this experiment to observe the crystalline surface. TFLX TS was suspended in pH 6.5 10&#160;mM BCB, <italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M adjusted by NaCl or Na<sub>2</sub>SO<sub>4</sub>, for 0.5, 3, and 5&#160;min at room temperature. The crystals were collected by vacuum filtration. The crystal surfaces were observed by scanning electron microscopy (SEM, TM-1000, Hitachi High-Technologies Corporation, Tokyo, Japan).</p></sec><sec id="Sec8"><title>Real-time Polarized Light Microscope Observation of TFLX TS Particles in Bicarbonate Buffer</title><p id="Par16">The experimental procedures of real-time PLM observation have been previously reported in detail. In brief, the coarse crystalline particles of TFLX TS were placed on a glass slide and covered with another glass slide. These two glass slides were tightly pinched by using two binder clips to fix the particles between the glass slides. BCB was penetrated from the side of the glass slide at room temperature (30 &#956;L, 10&#160;mM BCB, pH 6.5, <italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M adjusted by NaCl or Na<sub>2</sub>SO<sub>4</sub>).</p></sec><sec id="Sec9"><title>pH Solubility Profile Measurement</title><p id="Par17">TFLX FF (8 to 20&#160;mg) was added to an HCl or p-toluenesulfonic acid solution (5 to 10&#160;mL) in a 15&#160;mL test tube. The test tube was placed horizontally in a reciprocal shaker. After shaking for 48&#160;h at 37&#160;&#176;C (at 90&#160;rpm, motion width: 2.5&#160;cm), the sample was filtered (hydrophilic PVDF, &#966;&#8201;=&#8201;4.0&#160;mm, pore size: 0.22&#160;&#181;m, Merck). The first few droplets were discarded to avoid filter adsorption. The concentration of TFLX was measured as described above. After measuring the final pH (9615S-10D Standard ToupH electrode (HORIBA Advanced Techno Co., Ltd., Kyoto, Japan)), the residual particles were collected by vacuum filtration and analyzed by PXRD.</p></sec><sec id="Sec10"><title>Powder X-ray Diffraction</title><p id="Par18">A sample was placed on a zero-diffraction plate and analyzed by PXRD (Rigaku Ultima IV, Rigaku Corporation, Tokyo, Japan). Data was collected from 5 to 35&#176; (2&#952;) at a step size of 0.02&#176; and scanning speed of 10&#160;deg/min with Cu K&#945; radiation generated at 40&#160;mA and 40&#160;kV.</p></sec><sec id="Sec11"><title>Thermogravimetric Analysis/Differential Thermal Analysis</title><p id="Par19">The sample was placed in an aluminum pan (non-sealed) and analyzed by TG/DTA at 10&#176;C/min under nitrogen gas (DTG-60AH, Shimazu Corporation, Kyoto, Japan).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;I</label><caption><p>Compositions of Dissolution Media</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Buffer</th><th align="left" colspan="1" rowspan="1">&#946; (mM/pH)</th><th align="left" colspan="1" rowspan="1">NaHCO<sub>3</sub>(mM)</th><th align="left" colspan="1" rowspan="1">NaH<sub>2</sub>PO<sub>4</sub>&#8729;2H<sub>2</sub>O (mM)</th><th align="left" colspan="1" rowspan="1">HCl<sup>a</sup> (mM)</th><th align="left" colspan="1" rowspan="1">NaOH<sup>a</sup> (mM)</th><th align="left" colspan="1" rowspan="1">NaCl (mM)</th><th align="left" colspan="1" rowspan="1">Na<sub>2</sub>SO<sub>4</sub> (mM)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">BCB</td><td char="." align="char" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">2.0</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">0.62</td><td char="." align="char" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">46</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">2.0</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">0.62</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">138</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4.4</td><td align="left" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">3.3</td><td char="." align="char" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">44</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4.4</td><td align="left" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">3.3</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">131</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">PPB</td><td char="." align="char" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">1.6</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">0.57</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">46</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">1.6</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">0.57</td><td align="left" colspan="1" rowspan="1">137</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4.4</td><td align="left" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">8.0</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">3.1</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">42</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4.4</td><td align="left" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">8.0</td><td char="." align="char" colspan="1" rowspan="1">-</td><td char="." align="char" colspan="1" rowspan="1">3.1</td><td align="left" colspan="1" rowspan="1">126</td><td align="left" colspan="1" rowspan="1">-</td></tr></tbody></table><table-wrap-foot><p>a These concentrations were experimentally pre-determined to give pH 6.5 after adding to the NaHCO<sub>3</sub> and NaH<sub>2</sub>PO<sub>4</sub> solutions</p></table-wrap-foot></table-wrap></p></sec></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Dissolution Profiles of Tosufloxacin Tosylate Monohydrate</title><p id="Par20">The dissolution profiles of TFLX TS are shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>. TFLX TS dissolved less in the NaCl media than in the Na<sub>2</sub>SO<sub>4</sub> media. It also dissolved less in PPB than in BCB (at &#946;&#8201;=&#8201;4.4&#160;mM/pH), and less at &#946;&#8201;=&#8201;4.4&#160;mM/pH than at 0.88&#160;mM/pH. The maximum TFLX concentration was less than 32&#160;&#956;g/mL in all cases. The final pH values are shown in Table&#160;<xref rid="Tab2" ref-type="table">II</xref>. When &#946;&#8201;=&#8201;4.4&#160;mM/pH (10&#160;mM BCB and 8.0&#160;mM PPB), the final pH remained close to the initial pH (pH 6.5). When &#946;&#8201;=&#8201;0.88&#160;mM/pH (2.0&#160;mM BCB and 1.6&#160;mM PPB), the final pH value was slightly reduced. The pH reduction in the Na<sub>2</sub>SO<sub>4</sub> media was greater than that in the NaCl media.<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Dissolution profiles of TFLX TS in (<bold>A</bold>) bicarbonate buffer (BCB) and (<bold>B</bold>) phosphate buffer (PPB). Mean&#8201;&#177;&#8201;S.D., N&#8201;=&#8201;3.</p></caption><graphic id="MO2" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig2_HTML.jpg"/></fig><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;II</label><caption><p>Final pH Values After Dissolution Test with Initial pH Value of 6.5</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Buffer species</th><th align="left" colspan="1" rowspan="1">Buffer concentration (mM)<sup>a</sup></th><th align="left" colspan="1" rowspan="1">Ionic strength adjustment<sup>b</sup></th><th align="left" colspan="1" rowspan="1">Final pH<sup>c</sup></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">BCB</td><td char="." align="char" colspan="1" rowspan="1">2.0 (&#946;&#8201;=&#8201;0.88&#160;mM/pH)</td><td align="left" colspan="1" rowspan="1">NaCl</td><td char="." align="char" colspan="1" rowspan="1">6.44&#8201;&#177;&#8201;0.07</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Na<sub>2</sub>SO<sub>4</sub></td><td char="." align="char" colspan="1" rowspan="1">6.19&#8201;&#177;&#8201;0.03</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">10 (&#946;&#8201;=&#8201;4.4&#160;mM/pH)</td><td align="left" colspan="1" rowspan="1">NaCl</td><td char="." align="char" colspan="1" rowspan="1">6.52&#8201;&#177;&#8201;0.02</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Na<sub>2</sub>SO<sub>4</sub></td><td char="." align="char" colspan="1" rowspan="1">6.62&#8201;&#177;&#8201;0.11</td></tr><tr><td align="left" colspan="1" rowspan="1">PPB</td><td char="." align="char" colspan="1" rowspan="1">1.6 (&#946;&#8201;=&#8201;0.88&#160;mM/pH)</td><td align="left" colspan="1" rowspan="1">NaCl</td><td char="." align="char" colspan="1" rowspan="1">6.13&#8201;&#177;&#8201;0.01</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Na<sub>2</sub>SO<sub>4</sub></td><td char="." align="char" colspan="1" rowspan="1">5.82&#8201;&#177;&#8201;0.04</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">8.0 (&#946;&#8201;=&#8201;4.4&#160;mM/pH)</td><td align="left" colspan="1" rowspan="1">NaCl</td><td char="." align="char" colspan="1" rowspan="1">6.40&#8201;&#177;&#8201;0.02</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Na<sub>2</sub>SO<sub>4</sub></td><td char="." align="char" colspan="1" rowspan="1">6.45&#8201;&#177;&#8201;0.01</td></tr></tbody></table><table-wrap-foot><p>a Data in parentheses indicate buffer capacity (&#946;)</p><p>b <italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M</p><p>c Mean&#8201;&#177;&#8201;S.D., N&#8201;=&#8201;3</p></table-wrap-foot></table-wrap></p><p id="Par21">The PXRD data of residual particles are shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. In the NaCl media, the PXRD pattern of residual particles was identical to that of the TFLX 1/2HCl reference material. In the Na<sub>2</sub>SO<sub>4</sub> media, the PXRD pattern of residual particles was identical to that of the TFLX FF reference material.<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>PXRD patterns of residual particles in dissolution tests after 2&#160;h in (<bold>A</bold>) bicarbonate buffer (BCB) and (<bold>B</bold>) phosphate buffer (PPB).</p></caption><graphic id="MO3" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig3_HTML.jpg"/></fig></p><p id="Par22">Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref> shows the time course of the PXRD patterns of the residual particles in 10&#160;mM BCB. In the NaCl medium, the characteristic peaks of TFLX 1/2HCl appeared at early time points (&lt;&#8201;1&#160;min). In the Na<sub>2</sub>SO<sub>4</sub> medium, the characteristic peaks of TFLX FF appeared at early time points (&lt;&#8201;1&#160;min).<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>PXRD patterns of residual particles in dissolution tests at early time points in 10&#160;mM bicarbonate buffer containing NaCl or Na<sub>2</sub>SO<sub>4.</sub></p></caption><graphic id="MO4" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig4_HTML.jpg"/></fig></p></sec><sec id="Sec14"><title>Surface Morphology Observation by Scanning Electron Microscopy</title><p id="Par23">The SEM images of residual particles after mixing with BCB are shown in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>. Immediately after mixing with the media, fine needle-like crystals appeared on the crystal surface of TFLX TS.<fig id="Fig5" position="float" orientation="portrait"><label>Fig.&#160;5</label><caption><p>SEM images of the particles after mixing TFLX TS with pH 6.5 10&#160;mM BCB buffer solutions containing NaCl or Na<sub>2</sub>SO<sub>4</sub> (<italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M).</p></caption><graphic id="MO5" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig5_HTML.jpg"/></fig></p></sec><sec id="Sec15"><title>Real-time Polarized Light Microscopic Observation</title><p id="Par24">In real-time polarized light microscopic observation, the dissolution patterns were different between the NaCl and Na<sub>2</sub>SO<sub>4</sub> media (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>). In the Na<sub>2</sub>SO<sub>4</sub> medium, the precipitation of crystals near the TFLX TS particles and the change of the surface texture of the TFLX TS particles were observed. On the other hand, only the change of surface texture was observed in the NaCl medium.<fig id="Fig6" position="float" orientation="portrait"><label>Fig.&#160;6</label><caption><p>Real-time polarized light microscopic observation of TFLX TS in pH 6.5, 10&#160;mM BCB with NaCl and Na<sub>2</sub>SO<sub>4</sub> (<italic toggle="yes">I</italic>&#8201;=&#8201;0.14&#160;M).</p></caption><graphic id="MO6" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig6_HTML.jpg"/></fig></p></sec><sec id="Sec16"><title>pH Solubility Profile</title><p id="Par25">The pH solubility profiles were measured starting with TFLX FF (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>). The pH value was adjusted by HCl or p-toluenesulfonic acid. When pH was adjusted by p-toluenesulfonic acid, the residual particles below pH 2.3 were identified as TFLX TS by PXRD (Supplementary Material Figure S5). When pH was adjusted by HCl, the residual particles below pH 3.4 were identified as TFLX 1/2HCl (Supplementary Material Figure S6). The solubility product (<italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub>) of TFLX TS (<italic toggle="yes">K</italic><sub><italic toggle="yes">sp,TFLX TS</italic></sub> = [TFLX&#8729;H<sup>+</sup>][TS<sup>&#8722;</sup>]) was estimated to be 1.0&#8201;&#215;&#8201;10<sup>&#8211;5</sup> mol<sup>2</sup>/L<sup>2</sup> from the pH solubility profile (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>A). In the case of TFLX 1/2HCl, <italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub> is defined as <italic toggle="yes">K</italic><sub><italic toggle="yes">sp,TFLX 1/2HCl</italic></sub>&#8201;=&#8201;[TFLX&#8729;H<sup>+</sup>][TFLX][Cl<sup>&#8722;</sup>]. The <italic toggle="yes">K</italic><sub><italic toggle="yes">sp,TFLX 1/2HCl</italic></sub> value was estimated to be 1.0&#8201;&#215;&#8201;10<sup>&#8211;13</sup> mol<sup>3</sup>/L<sup>3</sup> from the pH solubility profile (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>B). The theoretical equations for the <italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub> and pH-controlled regions are shown in the Supplementary Material.<fig id="Fig7" position="float" orientation="portrait"><label>Fig.&#160;7</label><caption><p>pH solubility profiles of TFLX. pH was adjusted by (<bold>A</bold>) p-toluenesulfonic acid or (<bold>B</bold>) HCl. The horizontal axis shows the final equilibrium pH value. The red and blue lines are the theoretical curves for the <italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub> and pH-controlled regions, respectively. Mean&#8201;&#177;&#8201;S.D., N&#8201;=&#8201;3.</p></caption><graphic id="MO7" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig7_HTML.jpg"/></fig></p></sec></sec><sec id="Sec17"><title>Discussion</title><sec id="FPar1"><title>Effect of NaCl on the Dissolution Profile of Tosufloxacin Tosylate Monohydrate</title><p id="Par26">The dissolution profiles of TFLX TS differed in the presence and absence of NaCl in both BCB and PPB. Because TFLX TS is a non-HCl salt, this phenomenon cannot be explained by the common ionic effect of the chloride ion (Cl&#8315;) directly suppressing the dissociation of a salt-form drug. This is an important case showing that the dissolution profile of a salt-form drug can be impacted by physiological NaCl at a neutral pH, even when the counter ion is neither Na&#8314; nor Cl&#8315;.</p><p id="Par27">The residual particles after the dissolution test were TFLX 1/2HCl in the NaCl media and TFLX FF in the Na<sub>2</sub>SO<sub>4</sub> media. This explains the difference in the final bulk phase pH values between the NaCl and Na<sub>2</sub>SO<sub>4</sub> media at low &#946; (Table&#160;<xref rid="Tab2" ref-type="table">II</xref>). When TFLX was precipitated as a free form (zwitterionic form), p-toluenesulfonic acid was released in the solution, resulting in a decrease in the pH value. When TFLX 1/2HCl precipitated, the decrease in pH caused by the release of p-toluenesulfonic acid was partially offset by the removal of HCl, resulting in a smaller pH decrease. Because TFLX 1/2HCl is a complex of TFLX&#8729;H<sup>+</sup>, TFLX, and Cl<sup>&#8722;</sup>, its precipitation releases two p-toluenesulfonic acids and removes one HCl into/from the solution.</p></sec><sec id="FPar2"><title>Particle Surface Precipitation or Bulk Phase Precipitation?</title><p id="Par28">The results of SEM and RT-PLM studies, as well as the PXRD data of the residual particles at the early dissolution time point, indicated that TFLX 1/2HCl precipitated on the particle surface of TFLX TS in the NaCl media. In the previous bulk-phase pH-shift precipitation study [<xref ref-type="bibr" rid="CR22">22</xref>], TFLX FF precipitated from the bulk-phase solution even in the presence of NaCl, further supporting that the precipitation of TFLX 1/2HCl occurred on the particle surface of TFLX TS in the dissolution test.</p><p id="Par29">In addition, the dissolution profile of TFLX TS depended on the buffer species in the present study. In contrast, in the previous bulk phase pH-shift precipitation study [<xref ref-type="bibr" rid="CR19">19</xref>], the precipitation of TFLX FF at pH 6.5 was little affected by buffer species. Furthermore, the precipitation induction time of TFLX FF is slow at 30&#160;&#956;g/mL or less at pH 6.5 [<xref ref-type="bibr" rid="CR22">22</xref>]. Considering that the maximum TFLX concentration was less than 30&#160;&#956;g/mL in most cases of the present study, it is unlikely that rapid precipitation of TFLX FF occurred in the bulk phase. Together with the results of SEM and RT-PLM studies, as well as the PXRD data of the residual particles at the early dissolution time point, these results indicated that the precipitation of TFLX FF also occurred on the particle surface of TFLX TS in the Na<sub>2</sub>SO<sub>4</sub> media.</p></sec><sec id="FPar3"><title>Effect of Buffer Species and Buffer Capacity on Particle Surface Precipitation</title><p id="Par30">The dissolution profiles of TFLX TS in both the NaCl and Na<sub>2</sub>SO<sub>4</sub> media were affected by buffer species and buffer capacity, suggesting that the particle surface precipitations of TFLX 1/2HCl and TFLX FF were affected by these factors.</p><p>In the case of the precipitation of TFLX FF, the effect of buffer species and buffer capacity can be explained by their effect on the surface pH [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. The rates of precipitation processes (both nucleation and particle growth) depend on the supersaturation ratio (SR) of TFLX FF against the intrinsic solubility (<italic toggle="yes">S</italic><sub><italic toggle="yes">0</italic></sub>) (SR&#8201;=&#8201;[TFLX]<sub>ss</sub>/<italic toggle="yes"> S</italic><sub><italic toggle="yes">0</italic></sub>, where the subscript ss indicates the supersaturated concentration). At the surface of TFLX TS, the solution is in equilibrium with the solid of TFLX TS, so that the concentration of protonated TFLX becomes constant ([TFLX&#8729;H<sup>+</sup>]ss&#8201;=&#8201;<italic toggle="yes">K</italic><sub><italic toggle="yes">sp,TFLX TS</italic></sub><sup><italic toggle="yes">1/2</italic></sup>). At pH&#8201;&lt;&#8201;&#8201;&lt;&#8201;p<italic toggle="yes">K</italic><sub><italic toggle="yes">a2</italic></sub>, the concentration of the anionic form is negligible. Therefore, the supersaturation ratio of TFLX FF (SR<sub>TFLX FF</sub>) is expressed as,<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="d33e1197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${SR}_{TFLX FF}=\frac{{\left[TFLX\right]}_{ss}}{{S}_{0}}=\frac{{\left[TFLX\bullet {H}^{+}\right]}_{ss}}{{S}_{0}}\frac{{\left[TFLX\right]}_{ss}}{{\left[TFLX\bullet {H}^{+}\right]}_{ss}}=\frac{{{K}_{sp,TFLX TS}}^{1/2}}{{S}_{0}}\frac{{K}_{a1}}{[{H}^{+}]}$$\end{document}</tex-math><mml:math id="d33e1203" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">SR</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">TFLXFF</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mo>&#8729;</mml:mo><mml:msup><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mo>&#8729;</mml:mo><mml:msup><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mi>T</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:msub><mml:mi>S</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic position="anchor" orientation="portrait" xlink:href="11095_2025_3905_Article_Equ1.gif"/></alternatives></disp-formula></p><p><italic toggle="yes">K</italic><sub><italic toggle="yes">a1</italic></sub>/[H<sup>+</sup>] and SR<sub>TFLX FF</sub> steeply increase as pH increases (Fig.&#160;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8" position="float" orientation="portrait"><label>Fig.&#160;8</label><caption><p>pH dependency of <italic toggle="yes">K</italic><sub><italic toggle="yes">a1</italic></sub>/[H<sup>+</sup>].</p></caption><graphic id="MO8" position="float" orientation="portrait" xlink:href="11095_2025_3905_Fig8_HTML.jpg"/></fig></p><p>As discussed above, the precipitation of TFLX FF reduces the pH value. The surface pH neutralization rate of BCB is slower than that of PPB [<xref ref-type="bibr" rid="CR4">4</xref>], due to the slow hydration/dehydration rate of CO<sub>2</sub>. Therefore, the surface pH becomes lower in BCB than in PPB. The lower the surface pH, the lower SR<sub>TFLX FF</sub>, and the less precipitation of TFLX FF. Similarly, as the buffer capacity becomes lower, the surface pH becomes lower, and the precipitation of TFLX FF becomes less. Therefore, the dissolution of TFLX TS becomes greater in BCB than in PPB and at lower &#946;.</p><p>Similarly to the case of TFLX FF, the precipitation of TFLX 1/2HCl also reduces the pH value. The precipitation rate of TFLX 1/2HCl depends on the supersaturation ratio against the solubility product of TFLX 1/2HCl (SR <sub>TFLX 1/2HCl</sub>) (see SI for details).<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="d33e1352">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${SR}_{TFLX\, 1/2HCl}=\frac{{\left[TFLX\bullet {H}^{+}\right]}_{ss}{\left[TFLX\right]}_{ss}{\left[{Cl}^{-}\right]}_{ss}}{{K}_{sp,TFLX 1/2HCl}}=\frac{{K}_{sp,TFLX TS}}{{K}_{sp,TFLX 1/2HCl}}{\left[{Cl}^{-}\right]}_{ss}\frac{{K}_{a1}}{[{H}^{+}]}$$\end{document}</tex-math><mml:math id="d33e1358" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">SR</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mspace width="0.166667em"/><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn><mml:mi>H</mml:mi><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mo>&#8729;</mml:mo><mml:msup><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mfenced close="]" open="["><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mfenced close="]" open="["><mml:msup><mml:mrow><mml:mi mathvariant="italic">Cl</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:msup></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn><mml:mi>H</mml:mi><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mi>T</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mi>F</mml:mi><mml:mi>L</mml:mi><mml:mi>X</mml:mi><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn><mml:mi>H</mml:mi><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:msub><mml:mfenced close="]" open="["><mml:msup><mml:mrow><mml:mi mathvariant="italic">Cl</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:msup></mml:mfenced><mml:mrow><mml:mi mathvariant="italic">ss</mml:mi></mml:mrow></mml:msub><mml:mfrac><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic position="anchor" orientation="portrait" xlink:href="11095_2025_3905_Article_Equ2.gif"/></alternatives></disp-formula></p><p>Therefore, similarly to the case of TFLX FF, the precipitation of TFLX 1/2HCl becomes less in BCB than in PPB and at lower &#946;.</p></sec><sec id="FPar4"><title>pH&#8212;Solubility Profile of a Hemi-Hydrochloride Salt</title><p id="Par36">In this study, the hemi-hydrochloride salt of TFLX was formed in the NaCl media. In the literature, only a few hemi-hydrochloride salts of a drug have been reported [<xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>]. To estimate the solubility product of TFLX 1/2HCl and TFLX TS, the pH-solubility profile of TFLX was measured with the pH adjustment by HCl or p-toluenesulfonic acid, respectively. The experimental data were in good agreement with the theoretical line (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>B), further supporting the stoichiometry of hemi-hydrochloride (<italic toggle="yes">K</italic><sub><italic toggle="yes">sp,TFLX1/2HCl</italic></sub>&#8201;=&#8201;[TFLXH<sup>+</sup>][TFLX][Cl<sup>&#8722;</sup>]). The low <italic toggle="yes">K</italic><sub><italic toggle="yes">sp</italic></sub> value of TFLX 1/2HCl is in good agreement with its rapid precipitation in the presence of NaCl on the particle surface of TFLX TS.</p></sec><sec id="FPar5"><title>Diversity of Particle Surface Precipitation Phenomena</title><p id="Par37">In this study, TFLX 1/2 HCl was found to precipitate on the surface of TFLX TS particles in the NaCl media, whereas TFLX FF was found to precipitate in a Na<sub>2</sub>SO<sub>4</sub> media. Recently, it was reported that the dissolution profiles of pioglitazone HCl and dantrolene Na were affected by buffer species and buffer capacity, due to the precipitation of their free-form crystals at the particle surface [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In the case of prazosin HCl, the precipitation of a phosphate salt interfered with its dissolution in PPB, but not in BCB [<xref ref-type="bibr" rid="CR33">33</xref>]. Liquid&#8211;liquid phase separation (LLPS) of free-form drug molecules can also occur at the particle surface of salt-form drugs [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. These results suggest that various types of precipitation phenomena can occur at the particle surface of a salt-form drug, affecting the dissolution profile. To improve dissolution testing and physiologically based biopharmaceutical modeling, a better understanding of the mechanisms of particle surface precipitation is required.</p></sec><sec id="FPar6"><title>Limitations of this Study</title><p id="Par38">In this study, the effect of the other intestinal fluid constituents, such as bile micelles, on the dissolution profiles of TFLX TS was not investigated. Previously, the equilibrium solubility of TFLX was 1.6-fold higher in FaSSIF (3&#160;mM taurocholic acid/0.75&#160;mM egg lecithin) than in the blank FaSSIF without bile micelles [<xref ref-type="bibr" rid="CR24">24</xref>]. However, bile micelles had little effect on the dissolution profiles of TFLX TS [<xref ref-type="bibr" rid="CR24">24</xref>]. Further investigation is required to clarify the effect of bile micelles on the dissolution profiles of TFLX TS.</p><p>In conclusion, the poor dissolution profile of TFLX TS in biorelevant BCB containing NaCl was attributed to the particle surface precipitation of TFLX 1/2HCl. This study is an important case showing that the dissolution profile of a salt-form drug can be impacted by NaCl at pH 6.5, even when the counter ion is neither Na&#8314; nor Cl&#8315;. This is a rare case showing that an HCl salt can precipitate in the NaCl media at neutral pH, despite the drug molecules mainly existing as a free form (zwitterion) in the bulk phase solution. The findings of this study would be important for a better understanding of the mechanisms of particle surface precipitation.</p></sec></sec><sec id="Sec18" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="11095_2025_3905_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 1087 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to thank Dr. Alex Avdeef for supporting the interpretation of the pH solubility profiles.</p></ack><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by Ritsumeikan University. No funding support.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>The datasets generated during and/or analysed during the current study are available from the corresponding author on request.</p></notes><notes><title>Declarations</title><notes id="FPar7" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par40">The Author(s) declare(s) that they have no conflicts of interest to disclose.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>A</given-names></name><name name-style="western"><surname>Leigh</surname><given-names>M</given-names></name><name name-style="western"><surname>Kloefer</surname><given-names>B</given-names></name><name name-style="western"><surname>Dressman</surname><given-names>JB</given-names></name></person-group><article-title>Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3</article-title><source>Eur J Pharm Biopharm</source><year>2015</year><volume>94</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">26032292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejpb.2015.05.015</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Fuchs A, Leigh M, Kloefer B, Dressman JB. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. Eur J Pharm Biopharm. 2015;94:229&#8211;40.<pub-id pub-id-type="pmid">26032292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejpb.2015.05.015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>S</given-names></name></person-group><article-title>The use of biorelevant dissolution media to forecast the in vivo performance of a drug</article-title><source>AAPS J</source><year>2010</year><volume>12</volume><fpage>397</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">20458565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1208/s12248-010-9203-3</pub-id><pub-id pub-id-type="pmcid">PMC2895438</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J. 2010;12:397&#8211;406.<pub-id pub-id-type="pmid">20458565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1208/s12248-010-9203-3</pub-id><pub-id pub-id-type="pmcid">PMC2895438</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litou</surname><given-names>C</given-names></name><name name-style="western"><surname>Psachoulias</surname><given-names>D</given-names></name><name name-style="western"><surname>Vertzoni</surname><given-names>M</given-names></name><name name-style="western"><surname>Dressman</surname><given-names>J</given-names></name><name name-style="western"><surname>Reppas</surname><given-names>C</given-names></name></person-group><article-title>Measuring pH and buffer capacity in fluids aspirated from the fasted upper gastrointestinal tract of healthy adults</article-title><source>Pharm Res</source><year>2020</year><volume>37</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-019-2731-3</pub-id><pub-id pub-id-type="pmid">31989335</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Litou C, Psachoulias D, Vertzoni M, Dressman J, Reppas C. Measuring pH and buffer capacity in fluids aspirated from the fasted upper gastrointestinal tract of healthy adults. Pharm Res. 2020;37:1&#8211;12.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-019-2731-3</pub-id><pub-id pub-id-type="pmid">31989335</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Gousous</surname><given-names>J</given-names></name><name name-style="western"><surname>Salehi</surname><given-names>N</given-names></name><name name-style="western"><surname>Amidon</surname><given-names>GE</given-names></name><name name-style="western"><surname>Ziff</surname><given-names>RM</given-names></name><name name-style="western"><surname>Langguth</surname><given-names>P</given-names></name><name name-style="western"><surname>Amidon</surname><given-names>GL</given-names></name></person-group><article-title>Mass transport analysis of bicarbonate buffer: effect of the CO2-H2CO3 hydration-dehydration kinetics in the fluid boundary layer and the apparent effective p Ka controlling dissolution of acids and bases</article-title><source>Mol Pharm</source><year>2019</year><volume>16</volume><fpage>2626</fpage><lpage>2635</lpage><pub-id pub-id-type="pmid">31013101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.9b00187</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Al-Gousous J, Salehi N, Amidon GE, Ziff RM, Langguth P, Amidon GL. Mass transport analysis of bicarbonate buffer: effect of the CO2-H2CO3 hydration-dehydration kinetics in the fluid boundary layer and the apparent effective p Ka controlling dissolution of acids and bases. Mol Pharm. 2019;16:2626&#8211;35.<pub-id pub-id-type="pmid">31013101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.9b00187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galia</surname><given-names>E</given-names></name><name name-style="western"><surname>Nicolaides</surname><given-names>E</given-names></name><name name-style="western"><surname>H&#246;rter</surname><given-names>D</given-names></name><name name-style="western"><surname>L&#246;benberg</surname><given-names>R</given-names></name><name name-style="western"><surname>Reppas</surname><given-names>C</given-names></name><name name-style="western"><surname>Dressman</surname><given-names>JB</given-names></name></person-group><article-title>Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs</article-title><source>Pharm Res</source><year>1998</year><volume>15</volume><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">9619777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1011910801212</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Galia E, Nicolaides E, H&#246;rter D, L&#246;benberg R, Reppas C, Dressman JB. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res. 1998;15:698&#8211;705.<pub-id pub-id-type="pmid">9619777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1011910801212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takano</surname><given-names>R</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name><name name-style="western"><surname>Higashida</surname><given-names>A</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Machida</surname><given-names>M</given-names></name><name name-style="western"><surname>Aso</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test</article-title><source>Pharm Res</source><year>2006</year><volume>23</volume><fpage>AQ</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-006-0162-4</pub-id><pub-id pub-id-type="pmid">16715363</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, <italic toggle="yes">et al</italic>. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res. 2006;23: AQ.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-006-0162-4</pub-id><pub-id pub-id-type="pmid">16715363</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>JJ</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>DP</given-names></name><name name-style="western"><surname>Amidon</surname><given-names>GL</given-names></name></person-group><article-title>Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers</article-title><source>Mol Pharm</source><year>2009</year><volume>6</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">19183104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/mp800148u</pub-id><pub-id pub-id-type="pmcid">PMC3346296</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Sheng JJ, McNamara DP, Amidon GL. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol Pharm. 2009;6:29&#8211;39.<pub-id pub-id-type="pmid">19183104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/mp800148u</pub-id><pub-id pub-id-type="pmcid">PMC3346296</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Gousous</surname><given-names>J</given-names></name><name name-style="western"><surname>Amidon</surname><given-names>GL</given-names></name><name name-style="western"><surname>Langguth</surname><given-names>P</given-names></name></person-group><article-title>Toward biopredictive dissolution for enteric coated dosage forms</article-title><source>Mol Pharm</source><year>2016</year><volume>13</volume><fpage>1927</fpage><lpage>1936</lpage><pub-id pub-id-type="pmid">27139040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.6b00077</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Al-Gousous J, Amidon GL, Langguth P. Toward biopredictive dissolution for enteric coated dosage forms. Mol Pharm. 2016;13:1927&#8211;36.<pub-id pub-id-type="pmid">27139040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.6b00077</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fadda</surname><given-names>HM</given-names></name><name name-style="western"><surname>Merchant</surname><given-names>HA</given-names></name><name name-style="western"><surname>Arafat</surname><given-names>BT</given-names></name><name name-style="western"><surname>Basit</surname><given-names>AW</given-names></name></person-group><article-title>Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems</article-title><source>Int J Pharm</source><year>2009</year><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.08.003</pub-id><pub-id pub-id-type="pmid">19666093</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Fadda HM, Merchant HA, Arafat BT, Basit AW. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. Int J Pharm. 2009. 10.1016/j.ijpharm.2009.08.003.<pub-id pub-id-type="pmid">19666093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijpharm.2009.08.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krollik</surname><given-names>K</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaidas</surname><given-names>J</given-names></name><name name-style="western"><surname>Kubas</surname><given-names>H</given-names></name><name name-style="western"><surname>Weitschies</surname><given-names>W</given-names></name></person-group><article-title>The effect of buffer species on biorelevant dissolution and precipitation assays &#8211; comparison of phosphate and bicarbonate buffer</article-title><source>Eur J Pharm Biopharm</source><year>2022</year><pub-id pub-id-type="doi">10.1016/j.ejpb.2021.09.009</pub-id><pub-id pub-id-type="pmid">34592364</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Krollik K, Lehmann A, Wagner C, Kaidas J, Kubas H, Weitschies W. The effect of buffer species on biorelevant dissolution and precipitation assays &#8211; comparison of phosphate and bicarbonate buffer. Eur J Pharm Biopharm. 2022. 10.1016/j.ejpb.2021.09.009.<pub-id pub-id-type="pmid">34592364</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejpb.2021.09.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Dissolution profiles of poorly soluble drug salts in bicarbonate buffer</article-title><source>Pharm Res</source><year>2023</year><volume>40</volume><fpage>989</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">37024757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-023-03508-x</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Sakamoto A, Sugano K. Dissolution profiles of poorly soluble drug salts in bicarbonate buffer. Pharm Res. 2023;40:989&#8211;98.<pub-id pub-id-type="pmid">37024757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-023-03508-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Boni JE, Brickl RS, Dressman J. Is bicarbonate buffer suitable as a dissolution medium? J Pharm Pharmacol. 2010;59.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1211/jpp.59.10.0007</pub-id><pub-id pub-id-type="pmid">17910812</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Izutsu</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><name name-style="western"><surname>Abe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>D</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Simple bicarbonate buffer system for dissolution testing: Floating lid method and its application to colonic drug delivery system</article-title><source>J Drug Deliv Sci Technol</source><year>2021</year><volume>63</volume><fpage>102447</fpage></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Sakamoto A, Izutsu K, Yoshida H, Abe Y, Inoue D, Sugano K. Simple bicarbonate buffer system for dissolution testing: Floating lid method and its application to colonic drug delivery system. J Drug Deliv Sci Technol. 2021;63: 102447.</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikuta</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Kai</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets</article-title><source>Eur J Pharm Sci</source><year>2023</year><volume>180</volume><fpage>106326</fpage><pub-id pub-id-type="pmid">36347443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejps.2022.106326</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ikuta S, Nakagawa H, Kai T, Sugano K. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets. Eur J Pharm Sci. 2023;180: 106326.<pub-id pub-id-type="pmid">36347443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejps.2022.106326</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsui</surname><given-names>F</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Development of pH shift bicarbonate buffer dissolution test using floating lid and its feasibility for evaluating enteric-coated tablet</article-title><source>J Drug Deliv Sci Technol</source><year>2023</year><volume>83</volume><fpage>104438</fpage></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Matsui F, Sakamoto A, Sugano K. Development of pH shift bicarbonate buffer dissolution test using floating lid and its feasibility for evaluating enteric-coated tablet. J Drug Deliv Sci Technol. 2023;83: 104438.</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Ishida S, Lee S, Sinko B, Box K, Sugano K. Effect of bicarbonate buffer on artificial membrane permeation of drugs: Original scientific article. ADMET DMPK. 2025;2603&#8211;2603.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5599/admet.2603</pub-id><pub-id pub-id-type="pmcid">PMC11954139</pub-id><pub-id pub-id-type="pmid">40161892</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bapat</surname><given-names>P</given-names></name><name name-style="western"><surname>Schwabe</surname><given-names>R</given-names></name><name name-style="western"><surname>Paul</surname><given-names>S</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>Y-C</given-names></name><name name-style="western"><surname>Bergman</surname><given-names>C</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>LS</given-names></name></person-group><article-title>Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions</article-title><source>J Pharm Sci</source><year>2025</year><volume>114</volume><fpage>185</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">39186978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2024.08.013</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Bapat P, Schwabe R, Paul S, Tseng Y-C, Bergman C, Taylor LS. Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions. J Pharm Sci. 2025;114:185&#8211;98.<pub-id pub-id-type="pmid">39186978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2024.08.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valapil</surname><given-names>RR</given-names></name><name name-style="western"><surname>Polli</surname><given-names>JE</given-names></name></person-group><article-title>Impact of antioxidant addition on drug dissolution: Implications for NDSRI mitigation biowaivers</article-title><source>Int J Pharm</source><year>2025</year><pub-id pub-id-type="doi">10.1016/j.ijpharm.2025.125806</pub-id><pub-id pub-id-type="pmid">40460964</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Valapil RR, Polli JE. Impact of antioxidant addition on drug dissolution: Implications for NDSRI mitigation biowaivers. Int J Pharm. 2025. 10.1016/j.ijpharm.2025.125806.<pub-id pub-id-type="pmid">40460964</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijpharm.2025.125806</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Drug crystal precipitation in biorelevant bicarbonate buffer: a well-controlled comparative study with phosphate buffer</article-title><source>Mol Pharm</source><year>2024</year><volume>21</volume><fpage>2854</fpage><lpage>2864</lpage><pub-id pub-id-type="pmid">38718215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.4c00028</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Yamamoto H, Sugano K. Drug crystal precipitation in biorelevant bicarbonate buffer: a well-controlled comparative study with phosphate buffer. Mol Pharm. 2024;21:2854&#8211;64.<pub-id pub-id-type="pmid">38718215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.4c00028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garbacz</surname><given-names>G</given-names></name><name name-style="western"><surname>Klein</surname><given-names>S</given-names></name></person-group><article-title>Dissolution testing of oral modified-release dosage forms</article-title><source>J Pharm Pharmacol</source><year>2012</year><volume>64</volume><fpage>944</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">22686342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.2042-7158.2012.01477.x</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Garbacz G, Klein S. Dissolution testing of oral modified-release dosage forms. J Pharm Pharmacol. 2012;64:944&#8211;68.<pub-id pub-id-type="pmid">22686342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.2042-7158.2012.01477.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">FUJIFILM Toyama Chemical Co., Ltd. Tosufloxacin Drug Product Information. Available from: <ext-link ext-link-type="uri" xlink:href="https://asset-hc.fujifilm.com/hc/fftc/files/2021-02/f362d1aa933d8304db7032f306863bba/fftc_med_ozx_interview.pdf">https://asset-hc.fujifilm.com/hc/fftc/files/2021-02/f362d1aa933d8304db7032f306863bba/fftc_med_ozx_interview.pdf</ext-link>.&#160;Accessed 22 Aug 2024.</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name><name name-style="western"><surname>Shanker</surname><given-names>R</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Application of population balance model to simulate precipitation of weak base and zwitterionic drugs in gastrointestinal pH environment</article-title><source>Mol Pharm</source><year>2023</year><volume>20</volume><fpage>2266</fpage><lpage>2275</lpage><pub-id pub-id-type="pmid">36929729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.3c00088</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yamamoto H, Shanker R, Sugano K. Application of population balance model to simulate precipitation of weak base and zwitterionic drugs in gastrointestinal pH environment. Mol Pharm. 2023;20:2266&#8211;75.<pub-id pub-id-type="pmid">36929729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.3c00088</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okamoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Higashino</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Dissolution profiles of immediate release products of various drugs in biorelevant bicarbonate buffer: comparison with compendial phosphate buffer</article-title><source>Pharm Res</source><year>2024</year><volume>41</volume><fpage>959</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">38653942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-024-03701-6</pub-id><pub-id pub-id-type="pmcid">PMC11116250</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Okamoto N, Higashino M, Yamamoto H, Sugano K. Dissolution profiles of immediate release products of various drugs in biorelevant bicarbonate buffer: comparison with compendial phosphate buffer. Pharm Res. 2024;41:959&#8211;66.<pub-id pub-id-type="pmid">38653942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-024-03701-6</pub-id><pub-id pub-id-type="pmcid">PMC11116250</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarumi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Higashiguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Correlation between dissolution profiles of salt-form drugs in biorelevant bicarbonate buffer and oral drug absorption: importance of dose/ fluid volume ratio</article-title><source>Pharm Res</source><year>2025</year><volume>42</volume><fpage>623</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">40186046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-025-03854-y</pub-id><pub-id pub-id-type="pmcid">PMC12055928</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Tarumi Y, Higashiguchi Y, Sugano K. Correlation between dissolution profiles of salt-form drugs in biorelevant bicarbonate buffer and oral drug absorption: importance of dose/ fluid volume ratio. Pharm Res. 2025;42:623&#8211;37.<pub-id pub-id-type="pmid">40186046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-025-03854-y</pub-id><pub-id pub-id-type="pmcid">PMC12055928</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uekusa</surname><given-names>T</given-names></name><name name-style="western"><surname>Oki</surname><given-names>J</given-names></name><name name-style="western"><surname>Omori</surname><given-names>M</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>D</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>D</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Effect of buffer capacity on dissolution and supersaturation profiles of pioglitazone hydrochloride</article-title><source>J Drug Deliv Sci Technol</source><year>2020</year><volume>55</volume><fpage>101492</fpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Uekusa T, Oki J, Omori M, Watanabe D, Inoue D, Sugano K. Effect of buffer capacity on dissolution and supersaturation profiles of pioglitazone hydrochloride. J Drug Deliv Sci Technol. 2020;55: 101492.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>CA</given-names></name><name name-style="western"><surname>Rasband</surname><given-names>WS</given-names></name><name name-style="western"><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>671</fpage><pub-id pub-id-type="pmid">22930834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmcid">PMC5554542</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671.<pub-id pub-id-type="pmid">22930834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmcid">PMC5554542</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarumi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Dissolution profiles of high-dose salt-form drugs in bicarbonate buffer and phosphate buffer</article-title><source>J Pharm Sci</source><year>2025</year><volume>114</volume><fpage>477</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">39486519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2024.10.025</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Tarumi Y, Sugano K. Dissolution profiles of high-dose salt-form drugs in bicarbonate buffer and phosphate buffer. J Pharm Sci. 2025;114:477&#8211;85.<pub-id pub-id-type="pmid">39486519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2024.10.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urbansky</surname><given-names>ET</given-names></name><name name-style="western"><surname>Schock</surname><given-names>MR</given-names></name></person-group><article-title>Understanding, deriving, and computing buffer capacity</article-title><source>J Chem Educ</source><year>2009</year><volume>77</volume><fpage>1640</fpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Urbansky ET, Schock MR. Understanding, deriving, and computing buffer capacity. J Chem Educ. 2009;77:1640.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Effect of pH and buffer capacity of physiological bicarbonate buffer on precipitation of drugs</article-title><source>Mol Pharm</source><year>2025</year><volume>22</volume><fpage>1318</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">39893695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.4c00996</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Yamamoto H, Sugano K. Effect of pH and buffer capacity of physiological bicarbonate buffer on precipitation of drugs. Mol Pharm. 2025;22:1318&#8211;28.<pub-id pub-id-type="pmid">39893695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.4c00996</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L-Y</given-names></name><name name-style="western"><surname>He</surname><given-names>S-F</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C-Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Crystal structures, X-ray photoelectron spectroscopy, thermodynamic stabilities, and improved solubilities of 2-hydrochloride salts of vortioxetine</article-title><source>J Pharm Sci</source><year>2017</year><volume>106</volume><fpage>1069</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">28007563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2016.12.010</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Li J, Li L-Y, He S-F, Li S, Dong C-Z, Zhang L. Crystal structures, X-ray photoelectron spectroscopy, thermodynamic stabilities, and improved solubilities of 2-hydrochloride salts of vortioxetine. J Pharm Sci. 2017;106:1069&#8211;74.<pub-id pub-id-type="pmid">28007563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xphs.2016.12.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellena</surname><given-names>J</given-names></name><name name-style="western"><surname>Bocelli</surname><given-names>MD</given-names></name><name name-style="western"><surname>Honorato</surname><given-names>SB</given-names></name><name name-style="western"><surname>Ayala</surname><given-names>AP</given-names></name><name name-style="western"><surname>Doriguetto</surname><given-names>AC</given-names></name><name name-style="western"><surname>Martins</surname><given-names>FT</given-names></name></person-group><article-title>Base-paired and base-stacked structures of the anti-HIV drug lamivudine: a nucleoside DNA-mimicry with unprecedented topology</article-title><source>Cryst Growth Des</source><year>2012</year><volume>12</volume><fpage>5138</fpage><lpage>5147</lpage></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Ellena J, Bocelli MD, Honorato SB, Ayala AP, Doriguetto AC, Martins FT. Base-paired and base-stacked structures of the anti-HIV drug lamivudine: a nucleoside DNA-mimicry with unprecedented topology. Cryst Growth Des. 2012;12:5138&#8211;47.</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>C</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tao</surname><given-names>L</given-names></name><name name-style="western"><surname>Lv</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Measurement and correlation of solubility of cefmenoxime hydrochloride in pure solvents and binary solvent mixtures</article-title><source>J Chem Thermodyn</source><year>2016</year><volume>95</volume><fpage>63</fpage><lpage>71</lpage></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wang J, Xie C, Yin Q, Tao L, Lv J, Wang Y, <italic toggle="yes">et al</italic>. Measurement and correlation of solubility of cefmenoxime hydrochloride in pure solvents and binary solvent mixtures. J Chem Thermodyn. 2016;95:63&#8211;71.</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Fujimoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Wada</surname><given-names>K</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing</article-title><source>Drug Metab Pharmacokinet</source><year>2023</year><pub-id pub-id-type="doi">10.1016/j.dmpk.2023.100519</pub-id><pub-id pub-id-type="pmid">37393739</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Sudaki H, Fujimoto K, Wada K, Sugano K. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing. Drug Metab Pharmacokinet. 2023. 10.1016/j.dmpk.2023.100519.<pub-id pub-id-type="pmid">37393739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dmpk.2023.100519</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oki</surname><given-names>J</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>D</given-names></name><name name-style="western"><surname>Uekusa</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Mechanism of supersaturation suppression in dissolution process of acidic drug salt</article-title><source>Mol Pharm</source><year>2019</year><volume>16</volume><fpage>1669</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">30794420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.9b00006</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Oki J, Watanabe D, Uekusa T, Sugano K. Mechanism of supersaturation suppression in dissolution process of acidic drug salt. Mol Pharm. 2019;16:1669&#8211;77.<pub-id pub-id-type="pmid">30794420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.9b00006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uekusa</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name></person-group><article-title>Prediction of liquid-liquid phase separation at the dissolving drug salt particle surface</article-title><source>Mol Pharm</source><year>2023</year><volume>20</volume><fpage>3140</fpage><lpage>3149</lpage><pub-id pub-id-type="pmid">37183369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.3c00157</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Uekusa T, Sugano K. Prediction of liquid-liquid phase separation at the dissolving drug salt particle surface. Mol Pharm. 2023;20:3140&#8211;9.<pub-id pub-id-type="pmid">37183369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.molpharmaceut.3c00157</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>